KIORA PHARMACEUTICALS, INC. — Revenue by Fiscal Year
10 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/a5d11112-42d6-418a-b2ef-5469ccd5818c/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $0 | 2025-01-01 – 2025-12-31 | evidence 0001372514-26-000024 |
| FY 2024 | $16.0M | 2024-01-01 – 2024-12-31 | evidence 0001372514-25-000012 |
| FY 2023 | $0 | 2023-01-01 – 2023-12-31 | evidence 0001372514-25-000012 |
| FY 2021 | $0 | 2021-01-01 – 2021-12-31 | evidence 0001410578-22-000925 |
| FY 2020 | $12.1k | 2020-01-01 – 2020-12-31 | evidence 0001104659-21-041515 |
| FY 2019 | $2.7M | 2019-01-01 – 2019-12-31 | evidence 0001104659-20-029162 |
| FY 2018 | $1.7M | 2018-01-01 – 2018-12-31 | evidence 0001104659-20-029162 |
| FY 2017 | $407.5k | 2017-01-01 – 2017-12-31 | evidence 0001144204-19-011634 |
| FY 2016 | $669.3k | 2016-01-01 – 2016-12-31 | evidence 0001144204-17-010635 |
| FY 2015 | $0 | 2015-01-01 – 2015-12-31 | evidence 0001144204-17-010635 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
KIORA PHARMACEUTICALS, INC. — all facts · Net Income · Operating Income